PULSE BIOSCIENCES, INC. — Director's Dealing 2022

May 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2022-05-19

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-19	Stock Option (right to buy)	$2.14	A	20000	Acquired	2032-05-19	Common Stock (20000)	Direct
2022-05-19	Stock Option (right to buy)	$2.14	A	110467	Acquired	2032-05-19	Common Stock (110467)	Direct

Footnotes

F1: The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 19, 2022.

F2: The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on August 19, 2022.